The present invention relates to pharmaceutical compositions preferably comprising different molecules, monoclonal antibodies, each of which includes epsilon pi_. At the same time, the ErbB receptor 1 in the restricted area at different positions.The preferred antibody according to the present invention is a pie-dropping, humanized version of the monoclonal antibody 425 and mAb 225 under each mu_epsilon_delta. The invention relates to a tumor that is used and improved preferably through these components.
展开▼
